Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

HIV Infection

Free Subscription 16.07.2018 25 AIDS 8 AIDS Res Hum Retroviruses 2 Antimicrob Agents Chemother 1 BMC Pediatr 4 Clin Infect Dis 6 HIV Med 1 Int J Cancer 31 J Acquir Immune Defic Syndr 1 J Clin Invest 6 J Infect Dis 2 J Med Virol 1 J Pediatr 11 J Virol 1 JAMA 3 Lancet HIV 3 Lancet Infect Dis 1 Lancet Public Health 1 Lancet Respir Med 1 N Engl J Med 1 Nature 1 Pediatr Infect Dis J 1 Pediatrics 1 PLoS Med 16 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. NORET M, Balavoine S, Noret M, Pintado C, et al
   Daily or on demand oral TDF/FTC for HIV pre-exposure prophylaxis: experience from an hospital-based clinic in France.
   AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001939.
   PubMed     Text format     Abstract available
   
   
2. WORODRIA W, Ssempijja V, Hanrahan C, Ssegonja R, et al
   Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ counts.
   AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001941.
   PubMed     Text format     Abstract available
   
   
3. MSUKWA MT, Estill J, Haas AD, van Oosterhout JJ, et al
   Weight gain of HIV-exposed, uninfected children born before and after introduction of the "Option B+" programme in Malawi.
   AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001942.
   PubMed     Text format     Abstract available
   
   
4. HUNTER MD, Shenoy A, Dwork A, Elkind MSV, et al
   Brain vascular intima vulnerability among HIV-positive and negative individuals.
   AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001943.
   PubMed     Text format     Abstract available
   
   
5. LAHIRI CD, Brown NL, Ryan KJ, Acosta EP, et al
   HIV RNA persists in rectal tissue despite rapid plasma virologic suppression with dolutegravir-based therapy.
   AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001945.
   PubMed     Text format     Abstract available
   
   
6. MATSON TE, Mcginnis KA, Rubinsky AD, Frost MC, et al
   Gender and alcohol use: influences on HIV care continuum in a national cohort of patients with HIV.
   AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001946.
   PubMed     Text format     Abstract available
   
   
7. CLIFFORD GM, Siproudhis L, Piroth L, Poizot-Martin I, et al
   Determinants of high-grade anal intraepithelial lesions in HIV-positive men having sex with men.
   AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001947.
   PubMed     Text format     Abstract available
   
   
8. GOLOB JL, Stern J, Holte S, Kitahata MM, et al
   HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients.
   AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001948.
   PubMed     Text format     Abstract available
   
   
9. ULFHAMMER G, Eden A, Mellgren A, Fuchs D, et al
   Persistent CNS immune activation following > 10 years of effective HIV antiretroviral treatment.
   AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001950.
   PubMed     Text format     Abstract available
   
   
10. ADZHUBEI AA, Anashkina AA, Tkachev YV, Kravatsky YV, et al
    Modelling interaction between HIV-1 Nef and calnexin.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001951.
    PubMed     Text format     Abstract available
    
    
11. FICHT AL, Komba A, Bisimba J, Mlanga E, et al
    The time is now: closing the pediatric treatment gap and building resilience among female sex workers and their children.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001952.
    PubMed     Text format     Abstract available
    
    
12. ROSSOTTI R, Maggioni M, Merli M, Orcese C, et al
    Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject.
    AIDS. 2018;32:1727-1729.
    PubMed     Text format    
    
    
13. VERMUND SH, Kelley KF
    Impact of HIV on human papilloma virus-mediated cervical disease progression.
    AIDS. 2018;32:1715-1717.
    PubMed     Text format    
    
    
14. HEFFRON R, Mugo N, Hong T, Celum C, et al
    Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention.
    AIDS. 2018;32:1707-1713.
    PubMed     Text format     Abstract available
    
    
15. ORTEGA PAS, Saulle I, Mercurio V, Ibba SV, et al
    The interleukin 21 (IL 21)/ microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001938.
    PubMed     Text format     Abstract available
    
    
16. CHANG CC, Naranbhai V, Stern J, Roche M, et al
    Variation in cell associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator BMAL-1.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001937.
    PubMed     Text format     Abstract available
    
    
17. MUSINGUZI N, Muwonge T, Ngure K, Katabira E, et al
    Comparison of SMS self-reported adherence with other adherence measures in a demonstration project of HIV pre-exposure prophylaxis in Kenya and Uganda.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001955.
    PubMed     Text format     Abstract available
    
    
18. LIU Y, Blakely M, Sigel K, Thin TH, et al
    Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001957.
    PubMed     Text format     Abstract available
    
    
19. HARSLOF M, Knudsen AD, Benfield T, Nordestgaard BG, et al
    No evidence of increased risk of thyroid dysfunction in well-treated people living with HIV.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001954.
    PubMed     Text format     Abstract available
    
    
20. GORRY PR, Ahmad F, Mohl J, Alkhatib G, et al
    Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001953.
    PubMed     Text format     Abstract available
    
    
21. KELLY H, Chikandiwa A, Warman R, Segondy M, et al
    Associations of human gene EPB41L3 DNA methylation and cervical intraepithelial neoplasia in women living with HIV-1 in Africa.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001932.
    PubMed     Text format     Abstract available
    
    
22. DUARTE HA, Beck IA, Levine M, Kiptinness C, et al
    Implementation of a point mutation assay for HIV drug resistance testing in Kenya: performance, challenges, and cost.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001934.
    PubMed     Text format     Abstract available
    
    
23. MASABA R, Borkowf CB, Girde S, Zeh C, et al
    Adverse fetal and infant outcomes among HIV-infected women who received either nonnucleoside reverse transcriptase inhibitor-based or protease inhibitor-based antiretroviral therapy for prevention of mother-to-child transmission.
    AIDS. 2018;32:1625-1632.
    PubMed     Text format     Abstract available
    
    
24. LEE H, Wu XK, Genberg BL, Mugavero MJ, et al
    Beyond binary retention in HIV care: Predictors of the dynamic processes of patient engagement, disengagement, and re-entry into care in a US clinical cohort.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001936.
    PubMed     Text format     Abstract available
    
    
25. KOSS CA, Liu AY, Castillo-Mancilla J, Bacchetti P, et al
    Similar tenofovir hair concentrations in men and women after directly-observed: dosing of TDF/FTC: implications for PrEP adherence monitoring.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001935.
    PubMed     Text format     Abstract available
    
    

    
    AIDS Res Hum Retroviruses

26. SUGAWARA S, Thomas D, Balagopal A
    HIV-1 Infection and Type 1 Interferon: Navigating through Uncertain Waters.
    AIDS Res Hum Retroviruses. 2018 Jul 12. doi: 10.1089/AID.2018.0161.
    PubMed     Text format     Abstract available
    
    
27. LU X, Chen S, Zhao H, Li Y, et al
    Baseline investigation of HIV-1 primary drug resistance among newly diagnosed treatment-naive HIV-1 individuals in Hebei, China.
    AIDS Res Hum Retroviruses. 2018 Jul 12. doi: 10.1089/AID.2018.0142.
    PubMed     Text format     Abstract available
    
    
28. ZHOU JO, Ton T, Morriss JW, Nguyen D, et al
    Structural Insights from HIV-Antibody Co-Evolution and Related Immunization Studies.
    AIDS Res Hum Retroviruses. 2018 Jul 7. doi: 10.1089/AID.2018.0097.
    PubMed     Text format     Abstract available
    
    
29. SAFEEK RH, Hall KS, Lobelo F, Del Rio C, et al
    Low Physical Activity among Persons Living with HIV/AIDS is Associated with Poor Physical Function.
    AIDS Res Hum Retroviruses. 2018 Jul 7. doi: 10.1089/AID.2017.0309.
    PubMed     Text format     Abstract available
    
    
30. MANFIO VM, Ingrid Tasca K, Gatto M, da Silva VL, et al
    HIV-Infected Pregnant Women: A Microbial Translocation and Inflammatory Status Discussion.
    AIDS Res Hum Retroviruses. 2018 Jul 6. doi: 10.1089/AID.2018.0044.
    PubMed     Text format     Abstract available
    
    
31. NANCE R, Crane H, Ritchings C, Rosenblatt LC, et al
    Differentiation of Type 1 and Type 2 Myocardial Infarctions among HIV-infected patients requires adjudication due to overlap in risk factors.
    AIDS Res Hum Retroviruses. 2018 Jul 7. doi: 10.1089/AID.2018.0053.
    PubMed     Text format     Abstract available
    
    
32. VAN DER VELDEN Y, Villaudy J, Siteur-van Rijnstra E, van der Linden C, et al
    Protective efficacy of broadly neutralizing antibody PGDM1400 against HIV-1 challenge in humanized mice.
    AIDS Res Hum Retroviruses. 2018 Jul 13. doi: 10.1089/AID.2018.0114.
    PubMed     Text format     Abstract available
    
    
33. SUN J, Zhu B, Feng Y, Xie Y, et al
    Near Full-Length Genome Sequence of a Novel HIV-1 Recombinant Form (CRF01_AE/07_BC) Detected Among Men Who Have Sex with Men in Zhejiang, China.
    AIDS Res Hum Retroviruses. 2018 Jul 12. doi: 10.1089/AID.2018.0135.
    PubMed     Text format     Abstract available
    
    

    
    Antimicrob Agents Chemother

34. MEHTA R, Wolstenholme A, Di Lullo K, Fu C, et al
    Bioequivalence of a Fixed-Dose Combination Tablet of the Complete 2-Drug Regimen Dolutegravir and Rilpivirine for the Treatment of HIV-1 Infection.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00748.
    PubMed     Text format     Abstract available
    
    
35. SMITH SJ, Zhao XZ, Burke TR Jr, Hughes SH, et al
    HIV-1 integrase inhibitors that are broadly effective against drug-resistant mutants.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.01035.
    PubMed     Text format     Abstract available
    
    

    
    BMC Pediatr

36. CHINGONO R, Mebrahtu H, Mupambireyi Z, Simms V, et al
    Evaluating the effectiveness of a multi-component intervention on early childhood development in paediatric HIV care and treatment programmes: a randomised controlled trial.
    BMC Pediatr. 2018;18:222.
    PubMed     Text format     Abstract available
    
    

    
    Clin Infect Dis

37. DE VOUX A, Bernstein K, Bradley H, Kirkcaldy RD, et al
    Syphilis testing among sexually active men who have sex with men and who are receiving medical care for HIV in the United States-Medical Monitoring Project, 2013-2014.
    Clin Infect Dis. 2018 Jul 7. pii: 5050272. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
38. MUNCUNILL J, Baptista MJ, Hernandez-Rodriguez A, Dalmau J, et al
    Plasma EBV-load as an early biomarker and prognostic factor of HIV-related lymphomas.
    Clin Infect Dis. 2018 Jun 29. pii: 5047130. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
39. SIEGLER AJ, Mayer KH, Liu AY, Patel RR, et al
    Developing and assessing the feasibility of a home-based PrEP monitoring and support program.
    Clin Infect Dis. 2018 Jul 4. pii: 5049132. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
40. MCCLYMONT E, Lee M, Raboud J, Coutlee F, et al
    The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living with HIV.
    Clin Infect Dis. 2018 Jul 7. pii: 5050411. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    HIV Med

41. GALLIEN S, Massetti M, Flandre P, Leleu H, et al
    Comparison of 48-week efficacies of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimens: a systematic review and network meta-analysis.
    HIV Med. 2018 Jul 13. doi: 10.1111/hiv.12643.
    PubMed     Text format     Abstract available
    
    
42. ACOSTA MC, Kundro M, Viloria G, Peresin A, et al
    The role of brain biopsy in the clinical management of HIV-related focal brain lesions.
    HIV Med. 2018 Jul 13. doi: 10.1111/hiv.12646.
    PubMed     Text format     Abstract available
    
    
43. AHLSTROM MG, Knudsen A, Ullum H, Gerstoft J, et al
    Association between smoking status assessed with plasma-cotinine and inflammatory and endothelial biomarkers in HIV-positive and HIV-negative individuals.
    HIV Med. 2018 Jul 9. doi: 10.1111/hiv.12647.
    PubMed     Text format     Abstract available
    
    
44. HABERLEN SA, Jacobson LP, Palella FJ Jr, Dobs A, et al
    To T or not to T: Differences in Testosterone Use and Discontinuation by HIV Serostatus among Men who Have Sex with Men.
    HIV Med. 2018 Jul 10. doi: 10.1111/hiv.12644.
    PubMed     Text format     Abstract available
    
    
45. KOWALSKA JD, Bursa D, Gokengin D, Jilich D, et al
    HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.
    HIV Med. 2018 Jul 10. doi: 10.1111/hiv.12641.
    PubMed     Text format     Abstract available
    
    
46. SCHOLTEN M, Suarez I, Platten M, Kummerle T, et al
    To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.
    HIV Med. 2018 Jul 11. doi: 10.1111/hiv.12645.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

47. MCCORMACK V, Febvey-Combes O, Ginsburg O, Dos-Santos-Silva I, et al
    Breast cancer in women living with HIV: A first global estimate.
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31722.
    PubMed     Text format     Abstract available
    
    

    
    J Acquir Immune Defic Syndr

48. KIM MH, Wanless RS, Caviness AC, Golin R, et al
    Multimonth Prescription of Antiretroviral Therapy Among Children and Adolescents: Experiences From the Baylor International Pediatric AIDS Initiative in 6 African Countries.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S71-S80.
    PubMed     Text format     Abstract available
    
    
49. AMZEL A, Srivastava M, Isavwa A, Sanders J, et al
    Community-Based Interventions to Reach 95-95-95 for Children and Adolescents: An Exploratory Programmatic Review From Lesotho.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S81-S87.
    PubMed     Text format     Abstract available
    
    
50. SIMON KR, Flick RJ, Kim MH, Sabelli RA, et al
    Family Testing: An Index Case Finding Strategy to Close the Gaps in Pediatric HIV Diagnosis.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S88-S97.
    PubMed     Text format     Abstract available
    
    
51. MEDLEY AM, Hrapcak S, Golin RA, Dziuban EJ, et al
    Strategies for Identifying and Linking HIV-Infected Infants, Children, and Adolescents to HIV Treatment Services in Resource Limited Settings.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S98-S106.
    PubMed     Text format     Abstract available
    
    
52. MODI S, Broyles LN, Montandon M, Itoh M, et al
    Beyond Early Infant Diagnosis: Changing the Approach to HIV-Exposed Infants.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S107-S114.
    PubMed     Text format     Abstract available
    
    
53. WILLIS N, Napei T, Armstrong A, Jackson H, et al
    Zvandiri-Bringing a Differentiated Service Delivery Program to Scale for Children, Adolescents, and Young People in Zimbabwe.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S115-S123.
    PubMed     Text format     Abstract available
    
    
54. HARRISON K, Robinson J, Marks L, Blander J, et al
    ACTing in Partnership to Accelerate Impact.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S65-S70.
    PubMed     Text format     Abstract available
    
    
55. SIBERRY GK, Amzel A, Watts DH, Ahmed S, et al
    Supplement Introduction: Accelerating Children's HIV/AIDS Treatment (ACT) Initiative: Using What We Learned to Maintain the Pace to Close the Pediatric HIV Treatment Gap.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S63-S64.
    PubMed     Text format    
    
    
56. MACDONALD DM, Melzer AC, Collins G, Avihingsanon A, et al
    Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the Start Pulmonary Substudy.
    J Acquir Immune Defic Syndr. 2018 Jul 6. doi: 10.1097/QAI.0000000000001797.
    PubMed     Text format     Abstract available
    
    
57. CHANG E, Mapakshi SR, Mbang P, El-Mallawany NK, et al
    The impact of protease inhibitors on HIV-associated Kaposi sarcoma incidence: a systematic review.
    J Acquir Immune Defic Syndr. 2018 Jul 6. doi: 10.1097/QAI.0000000000001798.
    PubMed     Text format     Abstract available
    
    
58. BEHRENDS CN, Nugent AV, Des Jarlais DC, Frimpong JA, et al
    Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States.
    J Acquir Immune Defic Syndr. 2018 Jul 3. doi: 10.1097/QAI.0000000000001792.
    PubMed     Text format    
    
    
59. ZHANG Y, Sivay MV, Hudelson SE, Clarke W, et al
    Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068.
    J Acquir Immune Defic Syndr. 2018 Jul 3. doi: 10.1097/QAI.0000000000001793.
    PubMed     Text format     Abstract available
    
    
60. KNUDSEN AD, Gelpi M, Afzal S, Ronit A, et al
    Prevalence of Peripheral Artery Disease is Higher in Persons Living with HIV Compared to Uninfected Controls.
    J Acquir Immune Defic Syndr. 2018 Jul 3. doi: 10.1097/QAI.0000000000001795.
    PubMed     Text format     Abstract available
    
    
61. APONDI E, Humphrey JM, Sang E, Mwangi A, et al
    Trends Over Time for Adolescents Enrolling in HIV Care in Kenya, Tanzania, and Uganda from 2001-2014.
    J Acquir Immune Defic Syndr. 2018 Jul 4. doi: 10.1097/QAI.0000000000001796.
    PubMed     Text format     Abstract available
    
    
62. GRIMSRUD A, Bygrave H, Wilkinson L
    For Family-Centered Differentiated Service Delivery for HIV.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S124-S127.
    PubMed     Text format     Abstract available
    
    
63. PENAZZATO M, Sugandhi N, Essajee S, Doherty M, et al
    Getting Treatment and Care Services Right for Children and Adolescents to Reach High Viral Suppression.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S128-S133.
    PubMed     Text format     Abstract available
    
    
64. SAITO S, Chung H, Mahy M, Radin AK, et al
    Pediatric HIV Treatment Gaps in 7 East and Southern African Countries: Examination of Modeled, Survey, and Routine Program Data.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S134-S141.
    PubMed     Text format     Abstract available
    
    
65. CHOW FC, Wang H, Li Y, Mehta N, et al
    Cerebral Vasoreactivity Evaluated by the Breath Holding Challenge Correlates with Performance on A Cognitive Screening Test in Persons Living with Treated HIV Infection in China.
    J Acquir Immune Defic Syndr. 2018 Jul 9. doi: 10.1097/QAI.0000000000001805.
    PubMed     Text format    
    
    
66. CHEN M, Yen YF, Lan YC, Jen IA, et al
    Risk of Diffuse Infiltrative Lymphocytosis Syndrome in HIV-Infected Patients: A Nationwide Population-Based Cohort Study.
    J Acquir Immune Defic Syndr. 2018 Jul 9. doi: 10.1097/QAI.0000000000001802.
    PubMed     Text format     Abstract available
    
    
67. MARK D, Geng E, Vorkoper S, Essajee S, et al
    Making Implementation Science Work for Children and Adolescents Living With HIV.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S58-S62.
    PubMed     Text format     Abstract available
    
    
68. CIARANELLO A, Sohn AH, Collins IJ, Rothery C, et al
    Simulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and Adolescents.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S49-S57.
    PubMed     Text format     Abstract available
    
    
69. FORD D, Turner R, Turkova A, Penazzato M, et al
    Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S40-S48.
    PubMed     Text format     Abstract available
    
    
70. ABRAMS EJ, Ananworanich J, Archary M, Ngongondo M, et al
    Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S32-S39.
    PubMed     Text format     Abstract available
    
    
71. OLIVERAS C, Cluver L, Bernays S, Armstrong A, et al
    Nothing About Us Without RIGHTS-Meaningful Engagement of Children and Youth: From Research Prioritization to Clinical Trials, Implementation Science, and Policy.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S27-S31.
    PubMed     Text format     Abstract available
    
    
72. SOHN AH, Judd A, Mofenson L, Vicari M, et al
    Using Observational Data to Inform HIV Policy Change for Children and Youth.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S22-S26.
    PubMed     Text format     Abstract available
    
    
73. ARMSTRONG A, Nagata JM, Vicari M, Irvine C, et al
    A Global Research Agenda for Adolescents Living With HIV.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S16-S21.
    PubMed     Text format     Abstract available
    
    
74. PENAZZATO M, Irvine C, Vicari M, Essajee SM, et al
    A Global Research Agenda for Pediatric HIV.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S10-S15.
    PubMed     Text format     Abstract available
    
    
75. IRVINE C, Armstrong A, Nagata JM, Rollins N, et al
    Setting Global Research Priorities in Pediatric and Adolescent HIV Using the Child Health and Nutrition Research Initiative (CHNRI) Methodology.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S3-S9.
    PubMed     Text format     Abstract available
    
    
76. BEKKER LG, Siberry GK, Hirnschall G
    Ensuring Children and Adolescents Are Not Left Behind.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 1:S1-S2.
    PubMed     Text format    
    
    
77. KALIEL D, McCarthy E, Tayag J, Berry A, et al
    Sustainability and Accelerating Children's HIV/AIDS Treatment (ACT) Initiative: Lessons for the Next Treatment Surge.
    J Acquir Immune Defic Syndr. 2018;78 Suppl 2:S142-S146.
    PubMed     Text format     Abstract available
    
    
78. MOUCHERAUD C, Chasweka D, Nyirenda M, Schooley A, et al
    A Simple Screening Tool May Help Identify High-Risk Children for Targeted HIV Testing in Malawian Inpatient Wards.
    J Acquir Immune Defic Syndr. 2018 Jul 9. doi: 10.1097/QAI.0000000000001804.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Invest

79. CAUCHETEUX S, Piguet V
    Vaginal epidermal dendritic cells: defense against HIV-1 or a safe haven?
    J Clin Invest. 2018 Jul 9. pii: 121744. doi: 10.1172/JCI121744.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

80. LOPEZ-CORTES LF, Trujillo-Rodriguez M, Baez-Palomo A, Benmarzouk-Hidalgo OJ, et al
    Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
    J Infect Dis. 2018 Jul 6. pii: 5050122. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
81. GEBREMICAEL G, Kassa D, Quinten E, Alemayehu Y, et al
    Host gene expression kinetics during treatment of tuberculosis in HIV-coinfected individuals is independent of HAART therapy.
    J Infect Dis. 2018 Jul 2. pii: 5047436. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
82. NING T, Nie J, Huang W, Li C, et al
    Antigenic Drift of H7N9 Viral Hemagglutinin.
    J Infect Dis. 2018 Jul 5. pii: 5049177. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
83. STELLA-ASCARIZ N, Montejano R, Rodriguez-Centeno J, Alejos B, et al
    Blood Telomere Length Changes after Ritonavir-boosted Darunavir Combined with Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected with HIV-1.
    J Infect Dis. 2018 Jul 3. pii: 5048609. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
84. FULCHER JA, Hussain SK, Cook R, Li F, et al
    Effects of Substance Use and Sex Practices on the Intestinal Microbiome During HIV-1 Infection.
    J Infect Dis. 2018 Jul 2. pii: 5047923. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
85. JOSE S, Hamzah L, Jones R, Williams D, et al
    Chronic Kidney Disease Risk in African and Caribbean Populations with HIV.
    J Infect Dis. 2018 Jul 6. pii: 5049787. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Med Virol

86. SONG JE, Ahn MY, Kim WJ, Kim SW, et al
    Prevalence of CCR5 tropism among HIV-1-infected patients in South Korea.
    J Med Virol. 2018 Jul 7. doi: 10.1002/jmv.25254.
    PubMed     Text format     Abstract available
    
    
87. JOGEDA EL, Avi R, Pauskar M, Kallas E, et al
    Association of IFNlambda4 rs12979860 Polymorphism with the Acquisition of HCV and HIV Infections among People Who Inject Drugs.
    J Med Virol. 2018 Jul 10. doi: 10.1002/jmv.25258.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr

88. WARSZAWSKI J, Thomas C, Dialla O, Garrait V, et al
    T-Cell Receptor Excision Circles in HIV-Exposed, Uninfected Newborns Measured During a National Newborn Screening Program for Severe Combined Immunodeficiency.
    J Pediatr. 2018 Jul 3. pii: S0022-3476(18)30777.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

89. YAN Q, Zhao R, Shen C, Wang F, et al
    Upregulation of miR-711 mediates HIV-1 Vpr promotion of KSHV latency and induction of pro-proliferative/survival cytokines by targeting the Notch/NF-kappaB signaling axis.
    J Virol. 2018 Jul 5. pii: JVI.00580-18. doi: 10.1128/JVI.00580.
    PubMed     Text format     Abstract available
    
    
90. HEUSINGER E, Deppe K, Sette P, Krapp C, et al
    Preadaptation of SIVsmm facilitated Env-mediated counteraction of human tetherin by HIV-2.
    J Virol. 2018 Jul 5. pii: JVI.00276-18. doi: 10.1128/JVI.00276.
    PubMed     Text format     Abstract available
    
    
91. NOTO A, Procopio FA, Banga R, Suffiotti M, et al
    CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals.
    J Virol. 2018 Jul 5. pii: JVI.00901-18. doi: 10.1128/JVI.00901.
    PubMed     Text format     Abstract available
    
    
92. HOVANESSIAN AG, Soundaramourty C, Benferhat R, Le Grand R, et al
    Vaccination with the conserved caveolin-1 binding motif in HIV-1 glycoprotein gp41 delays the onset of viral infection and provides partial protection in SHIV-challenged cynomolgus macaques.
    J Virol. 2018 Jul 5. pii: JVI.00370-18. doi: 10.1128/JVI.00370.
    PubMed     Text format     Abstract available
    
    
93. KHAN SN, Sok D, Tran K, Movsesyan A, et al
    Targeting the HIV-1 spike and co-receptor with bi- and trispecific antibodies for single-component broad inhibition of entry.
    J Virol. 2018 Jul 5. pii: JVI.00384-18. doi: 10.1128/JVI.00384.
    PubMed     Text format     Abstract available
    
    
94. CHIEN H, Alston CI, Dix RD
    Suppressor of Cytokine Signaling (SOCS)1 and SOCS3 Are Stimulated Within the Eye During Experimental Murine Cytomegalovirus Retinitis in Mice With Retrovirus-Induced Immunosuppression.
    J Virol. 2018 Jul 5. pii: JVI.00526-18. doi: 10.1128/JVI.00526.
    PubMed     Text format     Abstract available
    
    
95. SCHWARTZ JA, Zhang H, Ende Z, Deymier MJ, et al
    Characterization of the plasmacytoid dendritic cell response to transmitted/founder and non-transmitted variants of HIV-1.
    J Virol. 2018 Jul 11. pii: JVI.00157-18. doi: 10.1128/JVI.00157.
    PubMed     Text format     Abstract available
    
    
96. OJWACH DBA, MacMillan D, Reddy T, Novitsky V, et al
    Pol-driven replicative capacity impacts disease progression in HIV-1 subtype C infection.
    J Virol. 2018 Jul 11. pii: JVI.00811-18. doi: 10.1128/JVI.00811.
    PubMed     Text format     Abstract available
    
    
97. BUFFONE C, Martinez-Lopez A, Fricke T, Opp S, et al
    Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Translocation in Non-dividing Cells.
    J Virol. 2018 Jul 11. pii: JVI.00648-18. doi: 10.1128/JVI.00648.
    PubMed     Text format     Abstract available
    
    
98. CHAN KW, Pan R, Costa M, Gorny MK, et al
    Structural Comparison of Human Anti-HIV-1 gp120 V3 MAbs of the Same Gene Usage Induced by Vaccination and Chronic Infection.
    J Virol. 2018 Jul 11. pii: JVI.00641-18. doi: 10.1128/JVI.00641.
    PubMed     Text format     Abstract available
    
    
99. MAVIGNER M, Habib J, Deleage C, Rosen E, et al
    SIV persistence in cellular and anatomic reservoirs in ART-suppressed infant rhesus macaques.
    J Virol. 2018 Jul 11. pii: JVI.00562-18. doi: 10.1128/JVI.00562.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

100. ABBASI J
     Anthony Fauci, MD: Working to End HIV/AIDS.
     JAMA. 2018 Jul 11. pii: 2687949. doi: 10.1001/jama.2018.8216.
     PubMed     Text format    
     
     

     
     Lancet HIV

101. HOLT E
     Conflict in Ukraine and a ticking bomb of HIV.
     Lancet HIV. 2018;5:e273-e274.
     PubMed     Text format    
     
     
102. HARRIS P
     The fourth joint conference of BHIVA with BASHH.
     Lancet HIV. 2018;5:e275.
     PubMed     Text format    
     
     
103. PAGE KR, Grieb SD, Nieves-Lugo K, Yamanis T, et al
     Enhanced immigration enforcement in the USA and the transnational continuity of HIV care for Latin American immigrants in deportation proceedings.
     Lancet HIV. 2018 Jul 6. pii: S2352-3018(18)30074.
     PubMed     Text format     Abstract available
     
     

     
     Lancet Infect Dis

104. NKENGASONG JN, Mbopi-Keou FX, Peeling RW, Yao K, et al
     Laboratory medicine in Africa since 2008: then, now, and the future.
     Lancet Infect Dis. 2018 Jul 3. pii: S1473-3099(18)30120.
     PubMed     Text format     Abstract available
     
     
105. WOODHALL SC, Gorwitz RJ, Migchelsen SJ, Gottlieb SL, et al
     Advancing the public health applications of Chlamydia trachomatis serology.
     Lancet Infect Dis. 2018 Jul 5. pii: S1473-3099(18)30159.
     PubMed     Text format     Abstract available
     
     
106. KALLA GCM, Voundi EV, Angwafo F 3rd, Belec L, et al
     Mass screening for hepatitis B and C and HIV in sub-Saharan Africa.
     Lancet Infect Dis. 2018;18:716.
     PubMed     Text format    
     
     

     
     Lancet Public Health

107. ZHENG S
     The growing threat of China's HIV epidemic.
     Lancet Public Health. 2018;3:e311.
     PubMed     Text format    
     
     

     
     Lancet Respir Med

108. SCHNIPPEL K, Ndjeka N, Maartens G, Meintjes G, et al
     Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study.
     Lancet Respir Med. 2018 Jul 9. pii: S2213-2600(18)30235.
     PubMed     Text format     Abstract available
     
     

     
     N Engl J Med

109. NEMES E, Geldenhuys H, Rozot V, Rutkowski KT, et al
     Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
     N Engl J Med. 2018;379:138-149.
     PubMed     Text format     Abstract available
     
     

     
     Nature

110. ROTH TL, Puig-Saus C, Yu R, Shifrut E, et al
     Reprogramming human T cell function and specificity with non-viral genome targeting.
     Nature. 2018 Jul 11. pii: 10.1038/s41586-018-0326.
     PubMed     Text format     Abstract available
     
     

     
     Pediatr Infect Dis J

111. MBUTHIA JK, Kabera BM, Karuga R, Ivui G, et al
     A Cross-sectional Study to Compare Hepatitis B Immunity in HIV-infected and HIV-uninfected Kenyan Children After Primary Hepatitis B Immunization.
     Pediatr Infect Dis J. 2018;37:e214-e215.
     PubMed     Text format     Abstract available
     
     

     
     Pediatrics

112. SADEGHIRAD B, Morgan RL, Zeraatkar D, Zea AM, et al
     Human and Bovine Colostrum for Prevention of Necrotizing Enterocolitis: A Meta-analysis.
     Pediatrics. 2018 Jul 10. pii: peds.2018-0767. doi: 10.1542/peds.2018-0767.
     PubMed     Text format     Abstract available
     
     

     
     PLoS Med

113. HARAUSZ EP, Garcia-Prats AJ, Law S, Schaaf HS, et al
     Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
     PLoS Med. 2018;15:e1002591.
     PubMed     Text format     Abstract available
     
     

     
     PLoS One

114. JOAG V, Sivro A, Yende-Zuma N, Imam H, et al
     Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women.
     PLoS One. 2018;13:e0200359.
     PubMed     Text format     Abstract available
     
     
115. SINGH NS, Smith J, Aryasinghe S, Khosla R, et al
     Evaluating the effectiveness of sexual and reproductive health services during humanitarian crises: A systematic review.
     PLoS One. 2018;13:e0199300.
     PubMed     Text format     Abstract available
     
     
116. JOAO EC, Ferreira ODC Jr, Gouvea MI, Teixeira MLB, et al
     Pregnant women co-infected with HIV and Zika: Outcomes and birth defects in infants according to maternal symptomatology.
     PLoS One. 2018;13:e0200168.
     PubMed     Text format     Abstract available
     
     
117. DE LIND VAN WIJNGAARDEN JW, Ching AD, Settle E, van Griensven F, et al
     "I am not promiscuous enough!": Exploring the low uptake of HIV testing by gay men and other men who have sex with men in Metro Manila, Philippines.
     PLoS One. 2018;13:e0200256.
     PubMed     Text format     Abstract available
     
     
118. MONTOY JCC, Dow WH, Kaplan BC
     Cash incentives versus defaults for HIV testing: A randomized clinical trial.
     PLoS One. 2018;13:e0199833.
     PubMed     Text format     Abstract available
     
     
119. GEORGE G, Chetty T, Strauss M, Inoti S, et al
     Costing analysis of an SMS-based intervention to promote HIV self-testing amongst truckers and sex workers in Kenya.
     PLoS One. 2018;13:e0197305.
     PubMed     Text format     Abstract available
     
     
120. GANTENBERG JR, King M, Montgomery MC, Galarraga O, et al
     Improving the impact of HIV pre-exposure prophylaxis implementation in small urban centers among men who have sex with men: An agent-based modelling study.
     PLoS One. 2018;13:e0199915.
     PubMed     Text format     Abstract available
     
     
121. OLUGBENGA I, Taiwo O, Laverty M, Ngige E, et al
     Clinic-based evaluation study of the diagnostic accuracy of a dual rapid test for the screening of HIV and syphilis in pregnant women in Nigeria.
     PLoS One. 2018;13:e0198698.
     PubMed     Text format     Abstract available
     
     
122. MIRKUZIE AH
     Correction: Implementation and outcomes of guideline revisions for the prevention of mother-to-child HIV transmission in Mother Support Programme, Addis Ababa, Ethiopia.
     PLoS One. 2018;13:e0200687.
     PubMed     Text format     Abstract available
     
     
123. SCHAEFER B, Viveiros A, Al-Zoairy R, Blach S, et al
     Disease burden of hepatitis C in the Austrian state of Tyrol - Epidemiological data and model analysis to achieve elimination by 2030.
     PLoS One. 2018;13:e0200750.
     PubMed     Text format     Abstract available
     
     
124. IVANUSIC D, Pietsch H, Konig J, Denner J, et al
     Absence of IL-10 production by human PBMCs co-cultivated with human cells expressing or secreting retroviral immunosuppressive domains.
     PLoS One. 2018;13:e0200570.
     PubMed     Text format     Abstract available
     
     
125. YOUNG SD, Zhang Q
     Using search engine big data for predicting new HIV diagnoses.
     PLoS One. 2018;13:e0199527.
     PubMed     Text format     Abstract available
     
     
126. TELELE NF, Kalu AW, Marrone G, Gebre-Selassie S, et al
     Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia.
     PLoS One. 2018;13:e0200505.
     PubMed     Text format     Abstract available
     
     
127. WEYDERT C, van Heertum B, Dirix L, De Houwer S, et al
     Y-box-binding protein 1 supports the early and late steps of HIV replication.
     PLoS One. 2018;13:e0200080.
     PubMed     Text format     Abstract available
     
     
128. NAN Y, Gao Y
     A machine learning method to monitor China's AIDS epidemics with data from Baidu trends.
     PLoS One. 2018;13:e0199697.
     PubMed     Text format     Abstract available
     
     
129. MUKHERJEE PK, Chandra J, Retuerto M, Tatsuoka C, et al
     Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection.
     PLoS One. 2018;13:e0200285.
     PubMed     Text format     Abstract available
     
     

     
     PLoS Pathog

130. MARSHALL VA, Labo N, Hao XP, Holdridge B, et al
     Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV.
     PLoS Pathog. 2018;14:e1007130.
     PubMed     Text format     Abstract available
     
     

     
     Proc Natl Acad Sci U S A

131. SHARMA S, Cermakova K, De Rijck J, Demeulemeester J, et al
     Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation.
     Proc Natl Acad Sci U S A. 2018 Jul 11. pii: 1803909115.
     PubMed     Text format     Abstract available
     
     

     
     Vaccine

132. APAYDIN KZ, Fontenot HB, Borba CPC, Shtasel DL, et al
     Three-dose HPV vaccine completion among sexual and gender minority young adults at a Boston community health center.
     Vaccine. 2018 Jul 5. pii: S0264-410X(18)30898.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: